SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-041479
Filing Date
2024-02-21
Accepted
2024-02-21 16:19:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d775786d424b3.htm 424B3 26848
2 GRAPHIC g775786g79x61.jpg GRAPHIC 68195
  Complete submission text file 0001193125-24-041479.txt   122117
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-276774 | Film No.: 24659785
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)